All Categories - InBrain Pharma

InBrain Pharma, a clinical stage biotech specialized in therapeutic solution development against neurodegenerative diseases, is thrilled to announce that it has been selected as a winner of the “First Factory” call for projects operated by Bpifrance on behalf of the French State, as part of the...

Lille, January 27, 2025 – InBrain Pharma, a clinical stage biotech specialized in therapeutic solution development against neurodegenerative diseases , is thrilled to announce the publication of the outstanding results of the Phase I/II DIVE-I monocentric study conducted at the Lille University...

Lille, September 25, 2024 - InBrain Pharma, a biopharmaceutical company specialized in neurodegenerative diseases, will present the positive results of its Phase I/II DIVE-I clinical trial for Parkinson’s disease at the upcoming International Congress of Parkinson’s Disease and Movement Disorders...